Angela Bella

Sevilla, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Metabolic and functional analysis including repetitive antigen stimulation provides a more accurate assessment for CAR-T cell product quality and long-term functionality.

Metabolic and functional analysis including repetitive antigen stimulation provides a more accurate assessment for CAR-T cell product quality and long-term functionality.

Journal: Journal of translational medicine

Published: December 01, 2025

BCL2-overexpression in donor lymphocytes reduces the risk of graft-versus-host disease.

BCL2-overexpression in donor lymphocytes reduces the risk of graft-versus-host disease.

Journal: Blood advances

Published: July 08, 2025

BCL2 overexpression in donor lymphocytes reduces the risk of graft-versus-host disease.

BCL2 overexpression in donor lymphocytes reduces the risk of graft-versus-host disease.

Journal: Blood advances

Published: July 08, 2025

Multicolor Flow Cytometry for Immune Characterization of Omental Metastasis in Peritoneal Carcinomatosis Mice Models.

Multicolor Flow Cytometry for Immune Characterization of Omental Metastasis in Peritoneal Carcinomatosis Mice Models.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: May 22, 2025

Unveiling the influence of CAR-negative T-cells: enhancing efficacy and ensuring safety in CAR-T therapies.

Unveiling the influence of CAR-negative T-cells: enhancing efficacy and ensuring safety in CAR-T therapies.

Journal: Journal of translational medicine

Published: April 07, 2025

Liposomal encapsulation of cholecalciferol mitigates in vivo toxicity and delays tumor growth.

Liposomal encapsulation of cholecalciferol mitigates in vivo toxicity and delays tumor growth.

Journal: Frontiers in immunology

Published: November 15, 2024

Intraperitoneal administration of mRNA encoding interleukin-12 for immunotherapy in peritoneal carcinomatosis.

Intraperitoneal administration of mRNA encoding interleukin-12 for immunotherapy in peritoneal carcinomatosis.

Journal: Journal of nanobiotechnology

Published: July 29, 2024

Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C.

Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C.

Journal: Journal for immunotherapy of cancer

Published: April 03, 2024

Peritoneal carcinomatosis in mouse models.

Peritoneal carcinomatosis in mouse models.

Journal: Methods in cell biology

Published: March 31, 2024

The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis.

The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis.

Journal: Oncoimmunology

Published: December 21, 2023

Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis.

Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis.

Journal: Journal for immunotherapy of cancer

Published: October 12, 2023

Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure.

Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure.

Journal: Molecular therapy. Nucleic acids

Published: March 08, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026